Volume 10, Issue 1 And 2 (8-2004)                   IJPCP 2004, 10(1 And 2): 4-10 | Back to browse issues page

XML Persian Abstract Print


1- , E-mail: alifarhoodian@yahoo.com
Abstract:   (39127 Views)
 

Abstract

Objectives: The present study was conducted to evaluate the efficacy of sodium valproate as an adjuvant treatment in patients afflicted with obsessive-compulsive disorder.

Method:42 patients diagnosed with obsessive-compulsive disorder participated in an eight week- long double blind study. The subjects were placed in two groups,one taking fluoxetine along with sodium valproate and the other group taking fluoxetine with placebo.The efficacy of this adjuvant was assessed by Yale-Brown Obsessive-Compulsive Scale and Beck Depression Inventory. Data were analyzed by t-test, Mann-Whitney, and analysis of variance with repeated measures.

Findings: 12 patients from the sodium valproate group and 11 patients from the placebo group com- pleted the project.This evaluation illustrated that efficacy of sodium valproate did not cause signi- ficant difference between two groups. Headache, anxiety,and insomnia were observed more com- monly in the placebo group the rate of tremor was higher in the sodium valproate group.

Results: Sodium valproate as an adjuvant treatment in patients with obsessive-compulsive disorder does not bind added efficacy in an eight weeklong treatment period.

 

Full-Text [PDF 221 kb]   (7442 Downloads)    
Type of Study: Original Research | Subject: Psychiatry and Psychology
Received: 2007/03/28 | Published: 2004/08/15

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.